文献速递糖尿病性腺与生殖内分泌

使用胰岛素泵或每日多次注射的1型糖尿病女性的胎儿过度生长与早产:EVOLVE研究队列的事后分析

Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort.
PubMed 文献 · Diabetes Care · 2024-01-01

基于EVOLVE研究2013-2018年17国2003例1型糖尿病孕妇的真实世界数据,比较胰岛素泵(723例)与每日多次注射(1280例)的妊娠结局。泵组大于胎龄儿(59.0% vs 52.2%,校正OR 1.36)和早产(39.6% vs 32.1%,校正OR 1.46)风险更高,校正HbA1c或妊娠期增重后结果不变。

要点

  • 泵组大于胎龄儿59.0% vs 每日多次注射组52.2%,校正OR 1.36(95%CI 1.09-1.70,P=0.007)。
  • 泵组早产39.6% vs 每日多次注射组32.1%,校正OR 1.46(95%CI 1.17-1.82,P<0.001)。
  • 校正HbA1c或妊娠期增重后,泵治疗与大于胎龄儿及早产的关联不变。

核心结论

  • 在持续葡萄糖监测或自动胰岛素输注广泛使用之前,1型糖尿病孕妇使用胰岛素泵治疗与每日多次注射相比,与更高的大于胎龄儿和早产风险相关。
  • 该关联似乎并非由HbA1c所反映的血糖控制差异或妊娠期增重所介导。

研究设计与样本

  • EVOLVE研究队列的事后分析,纳入2013-2018年17个国家真实世界环境下2003例1型糖尿病孕妇。
  • 其中723例使用胰岛素泵,1280例使用每日多次注射。

主要发现

  • 入组时(中位孕周8.6周,四分位距7-10周),泵组平均HbA1c较低(50.6±9.8 mmol/mol [6.8±0.9%] vs 53.6±13.8 mmol/mol [7.1±1.3%],P<0.001)。
  • 泵组糖尿病病程更长(18.4±7.8 vs 14.4±8.2年,P<0.001),视网膜病变患病率更高(35.3% vs 24.4%,P<0.001)。
  • 大于胎龄儿比例泵组59.0% vs 每日多次注射组52.2%,校正OR 1.36(95%CI 1.09-1.70,P=0.007)。
  • 早产比例泵组39.6% vs 每日多次注射组32.1%,校正OR 1.46(95%CI 1.17-1.82,P<0.001)。
  • 校正HbA1c或妊娠期增重后,上述结果不变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the risk of fetal overgrowth and preterm delivery in pregnant women with type 1 diabetes (T1D) treated with insulin pumps versus multiple daily injections (MDI) and examine whether possible differences were mediated through improved glycemic control or gestational weight gain during pregnancy. RESEARCH DESIGN AND METHODS: The risk of pregnancy and perinatal outcomes were evaluated in a cohort of 2,003 pregnant women with T1D enrolled from 17 countries in a real-world setting during 2013-2018. RESULTS: In total, 723 women were treated with pumps and 1,280 with MDI. At inclusion (median gestational weeks 8.6 [interquartile range 7-10]), pump users had lower mean HbA1c (mean ± SD 50.6 ± 9.8 mmol/mol [6.8 ± 0.9%] vs. 53.6 ± 13.8 mmol/mol [7.1 ± 1.3%], P < 0.001), longer diabetes duration (18.4 ± 7.8 vs. 14.4 ± 8.2 years, P < 0.001), and higher prevalence of retinopathy (35.3% vs. 24.4%, P < 0.001). Proportions of large for gestational age (LGA) offspring and preterm delivery were 59.0% vs. 52.2% (adjusted odds ratio [OR] 1.36 [95% CI 1.09; 1.70], P = 0.007) and 39.6% vs. 32.1% (adjusted OR 1.46 (95% CI 1.17; 1.82), P < 0.001), respectively. The results did not change after adjustment for HbA1c or gestational weight gain. CONCLUSIONS: Insulin pump treatment in pregnant women with T1D, prior to the widespread use of continuous glucose monitoring or automated insulin delivery, was associated with a higher risk of LGA offspring and preterm delivery compared with MDI in crude and adjusted analyses. This association did not appear to be mediated by differences in glycemic control as represented by HbA1c or by gestational weight gain.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Thorius IH, Husemoen LLN, Nordsborg RB, et al. Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort. Diabetes Care. 2024. PMID: 38128075. doi:10.2337/dc23-1281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。